Fischer Medical Ventures Share Price
24.63-0.03 (-0.12%)
-79.08% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
ADANIENTNSE
CPPLUSNSE
PREMIERENENSE
AEGISLOGNSE
REDINGTONNSE
HONASANSE
SGMARTNSE
LLOYDSENTNSE
MMTCNSE
CELLONSE
FISCHERNSE
Fischer Medical Ventures Share Price
24.63-0.03 (-0.12%)
-79.08% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 1098% | 179% |
| - | - | - | 1743% |
| - | - | - | -79% |
| 4% | 4% | 5% | 9% |
Peer Comparison
Symbol
ADANIENT
CPPLUS
PREMIERENE
AEGISLOG
REDINGTON
HONASA
SGMART
LLOYDSENT
MMTC
CELLO
FISCHER
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 2,593.3 | ₹353335 Cr | 61.58 | 11.02 | 97.19 | ₹9339 Cr |
| 3,890 | ₹47150 Cr | 98.79 | 12.07 | 43.68 | ₹368 Cr |
| 890 | ₹40334 Cr | 24.22 | 10.2 | 45.28 | ₹1510 Cr |
| 1,177.1 | ₹38645 Cr | 29.01 | 7.42 | 44.04 | ₹898 Cr |
| 335.25 | ₹25810 Cr | 15.17 | 6.22 | 24.36 | ₹1490 Cr |
| 457.2 | ₹14727 Cr | 59.17 | 2.77 | 8.99 | ₹200 Cr |
| 886.3 | ₹11095 Cr | 73.08 | 4.28 | 13.3 | ₹111 Cr |
| 60.4 | ₹9182 Cr | 81.77 | 0.38 | 0.91 | ₹283 Cr |
| 52.21 | ₹7833 Cr | 17.51 | 0.69 | 3.01 | ₹387 Cr |
| 342.35 | ₹7800 Cr | 24.93 | 3.32 | 17.46 | ₹332 Cr |
| 24.81 | ₹1722 Cr | 57.75 | 0.06 | 0.48 | ₹30 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ₹82 Cr | ₹98 Cr | ₹101 Cr | ₹86 Cr | ₹23 Cr | ₹49 Cr | ₹12 Cr | ₹40 Cr | ₹10 Cr | ₹21 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹7 Cr | ₹15 L | ₹38 L | ₹22 L | ₹74 L | ₹47 L |
| ₹83 Cr | ₹99 Cr | ₹102 Cr | ₹89 Cr | ₹31 Cr | ₹49 Cr | ₹12 Cr | ₹40 Cr | ₹11 Cr | ₹21 Cr |
| ₹72 Cr | ₹98 Cr | ₹80 Cr | ₹71 Cr | ₹20 Cr | ₹47 Cr | ₹12 Cr | ₹39 Cr | ₹11 Cr | ₹18 Cr |
| ₹13 Cr | ₹2 Cr | ₹23 Cr | ₹19 Cr | ₹12 Cr | ₹3 Cr | ₹88 L | ₹72 L | ₹48 L | ₹3 Cr |
| ₹4 Cr | ₹4 Cr | ₹64 L | ₹92 L | ₹66 L | ₹23 L | ₹7 L | ₹5 L | ₹13 L | ₹5 L |
| ₹8 Cr | -₹2 Cr | ₹21 Cr | ₹17 Cr | ₹10 Cr | ₹2 Cr | ₹25 L | ₹38 L | ₹8 L | ₹3 Cr |
| ₹4 Cr | -₹7 Cr | ₹19 Cr | ₹14 Cr | ₹5 Cr | ₹1 Cr | -₹17 L | ₹46 L | -₹12 L | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| — | — | — | — |
| ₹65 Cr | ₹64 Cr | ₹54 Cr | ₹17 L |
| ₹26 Cr | ₹30 Cr | ₹87 L | ₹0 |
| ₹293 Cr | ₹243 Cr | ₹27 Cr | -₹44 L |
| ₹293 Cr | ₹243 Cr | ₹27 Cr | -₹44 L |
| ₹384 Cr | ₹338 Cr | ₹81 Cr | -₹27 L |
| ₹76 L | ₹34 L | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹57 L |
| ₹26 L | ₹26 L | ₹0 | ₹0 |
| -₹2 Cr | ₹53,000 | ₹12 L | -₹11 L |
| ₹27 Cr | ₹17 Cr | ₹1 Cr | ₹0 |
| ₹99 L | ₹9 L | ₹0 | ₹0 |
| ₹26 Cr | ₹17 Cr | ₹1 Cr | ₹47 L |
| — | — | — | — |
| ₹103 Cr | ₹21 Cr | ₹2 Cr | ₹1 L |
| ₹23 Cr | ₹23 Cr | ₹2 Cr | ₹3 L |
| ₹72 Cr | ₹60 Cr | ₹0 | ₹0 |
| ₹61 Cr | ₹1 Cr | ₹90,000 | ₹0 |
| ₹258 Cr | ₹105 Cr | ₹4 Cr | ₹5 L |
| ₹669 Cr | ₹461 Cr | ₹86 Cr | ₹25 L |
| ₹72 Cr | ₹60 Cr | ₹0 | ₹57 L |
| — | — | — | — |
| ₹38 Cr | ₹27 Cr | ₹16 Cr | ₹0 |
| ₹6 Cr | ₹3 Cr | ₹1 Cr | ₹0 |
| ₹32 Cr | ₹24 Cr | ₹15 Cr | ₹0 |
| ₹3 Cr | ₹1 Cr | ₹0 | ₹0 |
| ₹118 Cr | ₹7 Cr | ₹1 Cr | ₹0 |
| ₹118 Cr | ₹7 Cr | ₹1 Cr | ₹0 |
| ₹50 Cr | ₹22 Cr | ₹0 | ₹0 |
| ₹49 Cr | ₹38 Cr | ₹0 | ₹0 |
| ₹251 Cr | ₹92 Cr | ₹16 Cr | ₹0 |
| — | — | — | — |
| ₹13 Cr | ₹9 Cr | ₹4 Cr | ₹0 |
| ₹289 Cr | ₹76 Cr | ₹23 Cr | ₹17 L |
| ₹25 Cr | ₹255 Cr | ₹38 Cr | ₹4 L |
| ₹6 Cr | ₹3 Cr | ₹45 L | ₹0 |
| ₹86 Cr | ₹26 Cr | ₹5 Cr | ₹4 L |
| ₹418 Cr | ₹369 Cr | ₹70 Cr | ₹25 L |
| ₹160 Cr | ₹263 Cr | ₹67 Cr | ₹20 L |
| ₹669 Cr | ₹461 Cr | ₹86 Cr | ₹25 L |
| ₹5 | ₹48 | ₹15 | -₹15 |
| ₹5 | ₹5 | ₹1 | -₹2 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Cash & Cash Equivalent of Subsidiaries under liquidations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ₹45 Cr | ₹2 Cr | ₹2 Cr | ₹0 |
| ₹15 Cr | ₹3 Cr | ₹25 L | ₹0 |
| -₹144 Cr | -₹90 Cr | -₹10 Cr | ₹0 |
| -₹84 Cr | -₹85 Cr | -₹7 Cr | ₹0 |
| -₹101 Cr | -₹86 Cr | -₹7 Cr | ₹0 |
| -₹5 Cr | -₹125 Cr | -₹31 Cr | ₹0 |
| ₹14 Cr | ₹315 Cr | ₹37 Cr | ₹0 |
| -₹92 Cr | ₹103 Cr | -₹2 Cr | ₹0 |
| ₹104 Cr | ₹95 L | ₹4 L | ₹0 |
| ₹0 | ₹0 | ₹3 Cr | ₹0 |
| ₹0 | ₹50,000 | ₹0 | ₹0 |
| ₹12 Cr | ₹104 Cr | ₹95 L | ₹0 |
Fundamental Ratios
Consolidated
Standalone
No results found
Fischer Medical Ventures Share Price
24.63-0.03 (-0.12%)
-79.08% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 6 out of 9 oscillators
RSI
31.57Sell
STOCH %K
33.14Neutral
MACD Level(12,26)
-2.26Sell
Ultimate Oscillator
48.09Sell
Aroon Oscillator
-86.00Sell
BOP
-0.07Sell
CCI
-81.70Neutral
Williams %R
-66.86Neutral
Momentum
-5.42Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
25.73Sell
SMA 9
25.33Sell
EMA 21
27.78Sell
SMA 21
28.14Sell
EMA 50
31.03Sell
SMA 50
32.14Sell
EMA 200
43.37Sell
SMA 200
36.36Sell
WMA 20
26.47Sell
Pivot
Pivot
Classic
Resistance 5
28.28
Resistance 4
27.42
Resistance 3
26.56
Resistance 2
25.70
Resistance 1
25.18
Pivot
24.84
Support 1
24.32
Support 2
23.98
Support 3
23.12
Support 4
22.26
Support 5
21.40
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Fischer Medical Ventures Share Price
24.63-0.03 (-0.12%)
-79.08% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 63.08% | 62.15% | 62.15% | 61.80% | 61.80% | 61.80% |
| 6.71% | 5.48% | 4.97% | 4.85% | 5.57% | 5.55% |
| 1.26% | 1.35% | 1.38% | 1.36% | 1.42% | 1.42% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 28.95% | 31.02% | 31.50% | 31.99% | 31.21% | 31.23% |
Bulk & block deals
Name
Trade Solvent Private Limited
L7 Hitech Private Limited
L7 Hitech Private Limited
Anand Mohan
Ravindradadajijilte
Mohammadzahidhussain
Arunkumar
Omkar Ashok Shinde
Suresh Sabanna Itkal
Kantilal B Shah
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 22 Sep 2026 | Purchase | 21.21 Cr | ₹32.95 | 64.37 L | Bulk | 0.929268 | NSE |
| 22 Sep 2026 | Purchase | 1.01 Cr | ₹32.98 | 3.05 L | Bulk | 0.044032 | NSE |
| 22 Sep 2026 | Sell | 21.21 Cr | ₹32.95 | 64.37 L | Bulk | 0.929268 | NSE |
| 10 Apr 2023 | Sell | 1 L | ₹79.80 | 1.26 K | Bulk | 0.000182 | BSE |
| 27 Dec 2021 | Sell | 90.75 K | ₹93.27 | 973 | Bulk | 0.00014 | BSE |
| 27 Dec 2021 | Purchase | 93.20 K | ₹93.20 | 1 K | Bulk | 0.000144 | BSE |
| 23 Aug 2021 | Purchase | 83.95 K | ₹90.07 | 932 | Bulk | 0.000135 | BSE |
| 09 Mar 2018 | Sell | 12.56 K | ₹12.56 | 1 K | Bulk | 0.000144 | BSE |
| 09 Mar 2018 | Purchase | 11.25 K | ₹12.50 | 900 | Bulk | 0.00013 | BSE |
| 09 Jan 2015 | Purchase | 77.18 K | ₹2.68 | 28.80 K | Bulk | 0.004158 | BSE |
Insider trading & SAST
Client name
Shankar Varadharajan & Others
Shankar Varadharajan & Pacs
Shankar Varadharajan & Pacs
Shankar Varadharajan & Pacs
Shankar Varadharajan & Others
Fmv Holdings Pte Ltd
Fmv Holdings Pte Ltd
Shankar Varadharajan
Fmv Holdings Pte Ltd
Shankar Varadharajan
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27 Aug 2026 | Promoter | Acquisition | 1.66 | 63 | 0 | — | 1.13 Cr | 13 Aug 2026 | Pref. Allotment | 42,69,72,531 | SAST | 29(2) | — |
| 27 Aug 2026 | Promoter | Acquisition | 0.35 | 62.5 | 0 | — | 23 L | 11 Aug 2026 | Pref. Allotment | 40,90,62,650 | SAST | 29(2) | — |
| 27 Aug 2026 | Promoter | Acquisition | 1.91 | 63.06 | 0 | — | 1.33 Cr | 14 Aug 2026 | Pref. Allotment | 44,03,08,440 | SAST | 29(2) | — |
| 27 Aug 2026 | Promoter | Acquisition | 1 | 62.66 | 0 | — | 66.32 L | 12 Aug 2026 | Pref. Allotment | 41,56,94,314 | SAST | 29(2) | — |
| 27 Aug 2026 | Promoter | Acquisition | 0.07 | 63.08 | 0 | — | 4.54 L | 17 Aug 2026 | Pref. Allotment | 44,07,62,650 | SAST | 29(2) | — |
| 18 Aug 2026 | Promoter | Acquisition | 0.065615 | 50.78 | 1.06 Cr | ₹23.40 | 4.54 L | 17 Aug 2026 | Conversion of security | 35,47,61,120 | Insider Trading | — | Equity |
| 17 Aug 2026 | Promoter | Acquisition | 1.092099 | 50.74 | 17.17 Cr | ₹23.40 | 73.36 L | 14 Aug 2026 | Conversion of security | 35,43,06,910 | Insider Trading | — | Equity |
| 17 Aug 2026 | Promoter | Acquisition | 0.893222 | 12.32 | 14.04 Cr | ₹23.40 | 60 L | 14 Aug 2026 | Conversion of security | 8,60,01,530 | Insider Trading | — | Equity |
| 17 Aug 2026 | Promoter | Acquisition | 1.059748 | 50.74 | 17.17 Cr | ₹23.40 | 73.36 L | 14 Aug 2026 | Conversion of security | 35,43,06,910 | Insider Trading | — | Equity |
| 17 Aug 2026 | Promoter | Acquisition | 0.866762 | 12.32 | 14.04 Cr | ₹23.40 | 60 L | 14 Aug 2026 | Conversion of security | 8,60,01,530 | Insider Trading | — | Equity |
Fischer Medical Ventures Share Price
24.63-0.03 (-0.12%)
-79.08% past 1 Year
Fischer Chemic Ltd is a certified supplier of APIs&intermediate Herbal Medicine Food Additives Cosmetics Raw Materials Laboratory Instrument&Chemicals PVC Modifier Aquaculture equipments etc. They have two manufacturing bases located in
Corporate Actions
Date
Type
Details
Company details
Fischer Medical Ventures Share Price
24.63-0.03 (-0.12%)
-79.08% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Fischer Medical Ventures Share Price
24.63-0.03 (-0.12%)
-79.08% past 1 Year
News
Fischer Medical Ventures Approves Rs 50 Crore Investment In Subsidiary Rights Issues
Equity
FISCHER
Fischer Medical Ventures expands Southeast Asia imaging footprint via new deployment initiative
Equity
FISCHER
Fischer Medical Ventures to hold analyst and investor meet on September 7
Equity
FISCHER
Fischer Medical Ventures subsidiary launches Clarion AI CT system in India
Equity
FISCHER
Fischer Medical Ventures gets CDSCO nod for Spincare wound care device
Equity
FISCHER
Fischer Medical Ventures informs about outcome of board meeting
Equity
FISCHER
Fischer Medical reports Profit after tax of Rs -8.98 Crores, in the March 2026 quarter
Equity
FISCHER
Fischer Medical Ventures informs about appointment of CS cum CO
Equity
FISCHER
Fischer Medical - Quaterly Results
Equity
FISCHER
Fischer Medical Ventures Q3 FY26 EBITDA Surges to Rs 21.60 Crores, Margin Expands to 21.34% YoY.
Equity
FISCHER
Fischer Medical Ventures Reports Q3 Net Profit of Rs 19.20 Crores, Revenue Rs 100 Crores YoY.
Equity
FISCHER
Fischer Medical Ventures Board Approves Restructuring of Malaysian Subsidiary Shareholding.
Equity
FISCHER
Fischer Medical reports Profit after tax of Rs -1.67 Crores, in the December 2025 quarter
Equity
FISCHER
Fischer Medical Ventures Restructures Pellucidcare Health Innovations Transfer to Subsidiary
Equity
FISCHER
Fischer Medical Ventures informs about reconstitution of committees
Equity
FISCHER
Fischer Medical Ventures informs about press release
Equity
FISCHER
Fischer Medical Ventures’ arm wins order worth Rs 9.29 crore
Equity
FISCHER
Fischer Medical Ventures informs about press release
Equity
FISCHER
Fischer Medical Ventures informs about audio recording of conference call
Equity
FISCHER
Fischer Medical Ventures informs about press release
Equity
FISCHER